Viewing nowBukwang Rosuvastatin Calcium Tablet 10 mg
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Bukwang Pharm Co., Ltd.

MFDS item code 201501710 · Approved 2015.03.31 · Insurance code 642203680
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used as an adjunct when dietary therapy and exercise alone do not adequately control primary hypercholesterolemia and mixed hyperlipidemia. It is also used to control cholesterol levels in patients with homozygous familial hypercholesterolemia in combination with diet or other lipid-lowering therapies. It is effective in lowering total cholesterol and LDL cholesterol in patients with hypercholesterolemia, delaying the progression of atherosclerosis. Additionally, it is used as an adjunct for patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in males over 50 years and females over 60 years with elevated high-sensitivity C-reactive protein and additional cardiovascular risk factors. This medication is effective in improving blood lipid levels and reducing cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, excluding heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
This medication should not be used in certain patients. For instance, individuals with allergies to its ingredients, active liver disease, muscle disorders, severe renal impairment, or pregnant or nursing women should not take this medication. Additionally, women of childbearing potential must take measures to reduce the likelihood of pregnancy and may only use this drug if they are fully aware of the risks to the fetus. Patients at high risk of muscle disorders should avoid high-dose use, and caution is required for those with a history of hypothyroidism or genetic muscle disorders. This medication contains lactose, so individuals with lactose intolerance should not take it. Patients who consume alcohol excessively or have a history of liver disease should undergo regular liver function tests before and during treatment with this medication. If symptoms of muscle pain or weakness appear, they should immediately inform their physician and undergo necessary tests. In cases of acute illness or severe conditions such as post-surgery, discontinuation of this medication may be necessary. This medication can interact with other drugs, so caution should be exercised, especially when taken with certain antivirals, immunosuppressants, antibiotics, and fibrate drugs, as concomitant use is contraindicated with some medications. During use, periodic tests of liver function and muscle-related parameters should be conducted, and consultation with healthcare providers is essential if abnormal symptoms arise. This medication should not be used during pregnancy or lactation, and women planning to become pregnant should employ appropriate contraceptive methods. In the case of overdose, there is no specific antidote, and treatment should be symptomatic along with liver function and muscle enzyme testing. This medication can cause dizziness while driving or operating machinery, so caution is advised. Finally, this medication may show higher systemic concentrations in Asians, necessitating potential dose adjustments.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, and systemic symptoms associated with drug reaction syndrome, patterned drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnestic syndrome, memory impairment, confusion, increased ALT, chest pain, myalgia, increased CK, increased AST, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature.
Pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Bukwang Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.